(Q44636627)

4 December 2017

title

Predictors and patterns of recurrence after resection of hepatocellular carcinoma (English)

1 reference

4 December 2017

1 reference

https://api.crossref.org/works/10.1016/J.JAMCOLLSURG.2003.07.003

26 March 2024

2

Yuman Fong

1 reference

4 December 2017

5

Ronald P DeMatteo

1 reference

4 December 2017

1

Charles Cha

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14585409

26 March 2024

author name string

William R. Jarnagin

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14585409

26 March 2024

Leslie H. Blumgart

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14585409

26 March 2024

language of work or name

1 reference

1 November 2003

1 reference

full work available at URL

4 December 2017

https://api.elsevier.com/content/article/PII:S1072751503008159?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.JAMCOLLSURG.2003.07.003

https://api.elsevier.com/content/article/PII:S1072751503008159?httpAccept=text/plain

26 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.JAMCOLLSURG.2003.07.003

Journal of the American College of Surgeons

26 March 2024

published in

1 reference

4 December 2017

volume

197

1 reference

4 December 2017

issue

5

1 reference

4 December 2017

page(s)

753-758

1 reference

4 December 2017

cites work

Neoplasms of the liver

1

1 reference

https://api.crossref.org/works/10.1016/J.JAMCOLLSURG.2003.07.003

26 March 2024

Hepatocellular carcinoma

2

1 reference

https://api.crossref.org/works/10.1016/J.JAMCOLLSURG.2003.07.003

Rising incidence of hepatocellular carcinoma in the United States

26 March 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.JAMCOLLSURG.2003.07.003

Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients

26 March 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.JAMCOLLSURG.2003.07.003

The natural history of hepatocellular carcinoma. A study of 100 untreated cases

26 March 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.JAMCOLLSURG.2003.07.003

Liver resections in cirrhotic patients: a Western experience

26 March 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.JAMCOLLSURG.2003.07.003

Predictive factors for long term prognosis after partial hepatectomy for patients with hepatocellular carcinoma in Japan. The Liver Cancer Study Group of Japan

26 March 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.JAMCOLLSURG.2003.07.003

Liver resection for hepatocellular carcinoma. Results of 229 consecutive patients during 11 years

26 March 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.JAMCOLLSURG.2003.07.003

Effect of age on antipyrine metabolism in patients with gastric cancer

26 March 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.JAMCOLLSURG.2003.07.003

Limited Hepatic Resection Effective for Selected Cirrhotic Patients with Primary Liver Cancer

26 March 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.JAMCOLLSURG.2003.07.003

Hepatic resection in 120 patients with hepatocellular carcinoma

26 March 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.JAMCOLLSURG.2003.07.003

Hepatic resection for hepatocellular carcinoma. Clinical features and long-term prognosis

26 March 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.JAMCOLLSURG.2003.07.003

Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients

26 March 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.JAMCOLLSURG.2003.07.003

Surgical treatment of hepatocellular carcinomas in noncirrhotic liver: experience with 68 liver resections.

26 March 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.JAMCOLLSURG.2003.07.003

Hepatocellular Carcinoma and Cirrhosis

26 March 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.JAMCOLLSURG.2003.07.003

An analysis of 412 cases of hepatocellular carcinoma at a Western center

26 March 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.JAMCOLLSURG.2003.07.003

Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years

26 March 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.JAMCOLLSURG.2003.07.003

Improved results of liver resection for hepatocellular carcinoma on cirrhosis give the procedure added value

26 March 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.JAMCOLLSURG.2003.07.003

Surgery and ablative therapy for hepatocellular carcinoma

26 March 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.JAMCOLLSURG.2003.07.003

Postoperative hepatitis status as a significant risk factor for recurrence in cirrhotic patients with small hepatocellular carcinoma

26 March 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.JAMCOLLSURG.2003.07.003

Recurrence of hepatocellular carcinoma after surgery

26 March 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.JAMCOLLSURG.2003.07.003

Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation

26 March 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.JAMCOLLSURG.2003.07.003

Postoperative recurrence of hepatocellular carcinoma. Two hundred five consecutive patients who underwent hepatic resection in 15 years.

26 March 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.JAMCOLLSURG.2003.07.003

Surgical resection for recurrent hepatocellular carcinoma: prognosis and analysis of risk factors.

26 March 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.JAMCOLLSURG.2003.07.003

Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: a prospective randomised trial

26 March 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.JAMCOLLSURG.2003.07.003

Treatment of unresectable primary liver cancer with intrahepatic fluorodeoxyuridine and mitomycin C through an implantable pump

26 March 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.JAMCOLLSURG.2003.07.003

26 March 2024

Identifiers

1 reference

4 December 2017

1 reference